Pluto Biosciences
Pluto: A B2B SaaS platform for collaborative management, analysis, and visualization of biological data.
Founded
2020Pluto: A B2B SaaS platform for collaborative management, analysis, and visualization of biological data.
Pluto Biosciences, founded with the mission to revolutionize biological data management, offers a B2B SaaS platform designed for collaborative analysis and visualization of biological data. The company's core vision is to accelerate scientific discovery and innovation in biotechnology, drug discovery, and academic research. Pluto's platform enables teams to translate raw data into actionable insights, facilitating processes such as target identification, biomarker discovery, and comparative translational studies.
Notable figures affiliated with Pluto Biosciences include experienced professionals from the biotechnology and software industries. The company has attracted investments from prominent venture capital firms focused on life sciences and technology. Key achievements include the successful deployment of their platform in various research institutions and biotech companies, significantly reducing the time required for data analysis and increasing reproducibility and data accessibility. Pluto Biosciences' impact is marked by its contribution to faster scientific discoveries and higher-quality research publications.
Companies similar to Pluto Biosciences include Dotmatics, Datirium, TetraScience and Omix.ai.
Pluto Biosciences was founded in 2020.
Pluto Biosciences' headquarters is located in Denver, CO, US.
Pluto Biosciences' most recent funding round was for $3.7M (USD) in May 2023.
As of May 2, 2023, Pluto Biosciences has disclosed funding of $4.7M (USD). Undisclosed round amounts are excluded.
Pluto Biosciences has 29 employees as of Feb 5, 2024.
Omix.ai
